Literature DB >> 18772881

Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.

Christy A Thomson1, Steve Bryson, Gary R McLean, A Louise Creagh, Emil F Pai, John W Schrader.   

Abstract

Immunoglobulin genes are generated somatically through specialized mechanisms resulting in a vast repertoire of antigen-binding sites. Despite the stochastic nature of these processes, the V-genes that encode most of the antigen-combining site are under positive evolutionary selection, raising the possibility that V-genes have been selected to encode key structural features of binding sites of protective antibodies against certain pathogens. Human, neutralizing antibodies to human cytomegalovirus that bind the AD-2S1 epitope on its gB envelope protein repeatedly use a pair of well-conserved, germline V-genes IGHV3-30 and IGKV3-11. Here, we present crystallographic, kinetic and thermodynamic analyses of the binding site of such an antibody and that of its primary immunoglobulin ancestor. These show that these germline V-genes encode key side chain contacts with the viral antigen and thereby dictate key structural features of the hypermutated, high-affinity neutralizing antibody. V-genes may thus encode an innate, protective immunological memory that targets vulnerable, invariant sites on multiple pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772881      PMCID: PMC2567409          DOI: 10.1038/emboj.2008.179

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.

Authors:  Wesley E. Stites
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

2.  X-ray snapshots of the maturation of an antibody response to a protein antigen.

Authors:  Yili Li; Hongmin Li; Feng Yang; Sandra J Smith-Gill; Roy A Mariuzza
Journal:  Nat Struct Biol       Date:  2003-06

Review 3.  The evolutionary and structural 'logic' of antigen receptor diversity.

Authors:  Mark M Davis
Journal:  Semin Immunol       Date:  2004-08       Impact factor: 11.130

4.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

5.  The imprint of somatic hypermutation on the repertoire of human germline V genes.

Authors:  I M Tomlinson; G Walter; P T Jones; P H Dear; E L Sonnhammer; G Winter
Journal:  J Mol Biol       Date:  1996-03-15       Impact factor: 5.469

Review 6.  Genetic control of early antibody responses.

Authors:  O Mäkelä; M Kaartinen
Journal:  Immunol Rev       Date:  1988-10       Impact factor: 12.988

7.  The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.

Authors:  H Meyer; Y Masuho; M Mach
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

8.  Somatic mutations can lead to a loss of superantigenic and polyreactive binding.

Authors:  Pablo Oppezzo; Gérard Dumas; Jean-Pierre Bouvet; Carlos Robello; Alfonso Cayota; Juan Carlos Pizarro; Guillaume Dighiero; Otto Pritsch
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

9.  Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55.

Authors:  Y Ohizumi; H Suzuki; Y Matsumoto; Y Masuho; Y Numazaki
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

10.  B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen.

Authors:  J Lang; M Jackson; L Teyton; A Brunmark; K Kane; D Nemazee
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  33 in total

1.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization.

Authors:  Hongyuan Mao; James J Graziano; Tyson M A Chase; Cornelia A Bentley; Omar A Bazirgan; Neil P Reddy; Byeong Doo Song; Vaughn V Smider
Journal:  Nat Biotechnol       Date:  2010-10-24       Impact factor: 54.908

2.  Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

Authors:  Remy Robert; Marie-Paule Lefranc; Anahit Ghochikyan; Michael G Agadjanyan; David H Cribbs; William E Van Nostrand; Kim L Wark; Olan Dolezal
Journal:  Mol Immunol       Date:  2010 Nov-Dec       Impact factor: 4.407

3.  Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.

Authors:  Jean-Philippe Julien; Nerea Huarte; Rubén Maeso; Stefka G Taneva; Annie Cunningham; José L Nieva; Emil F Pai
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody.

Authors:  Louise Scharf; Anthony P West; Han Gao; Terri Lee; Johannes F Scheid; Michel C Nussenzweig; Pamela J Bjorkman; Ron Diskin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-22       Impact factor: 11.205

5.  Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets.

Authors:  Krista M McCutcheon; Julia Gray; Natalie Y Chen; Keyi Liu; Minha Park; Stote Ellsworth; Ralph A Tripp; S Mark Tompkins; Scott K Johnson; Shelly Samet; Lenore Pereira; Lawrence M Kauvar
Journal:  MAbs       Date:  2014-01-08       Impact factor: 5.857

6.  Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies.

Authors:  Thaddeus M Davenport; Jason Gorman; M Gordon Joyce; Tongqing Zhou; Cinque Soto; Miklos Guttman; Stephanie Moquin; Yongping Yang; Baoshan Zhang; Nicole A Doria-Rose; Shiu-Lok Hu; John R Mascola; Peter D Kwong; Kelly K Lee
Journal:  Structure       Date:  2016-07-28       Impact factor: 5.006

7.  Searching for a Serological Correlate of Protection for a CMV Vaccine.

Authors:  M R Schleiss
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

8.  B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure.

Authors:  Patrizia Farci; Giacomo Diaz; Zhaochun Chen; Sugantha Govindarajan; Ashley Tice; Liane Agulto; Stefania Pittaluga; Denali Boon; Claro Yu; Ronald E Engle; Mark Haas; Richard Simon; Robert H Purcell; Fausto Zamboni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

9.  Characterization of pathogenic human monoclonal autoantibodies against GM-CSF.

Authors:  Yanni Wang; Christy A Thomson; Lenka L Allan; Linda M Jackson; Melanie Olson; Timothy R Hercus; Tracy L Nero; Amanda Turner; Michael W Parker; Angel L Lopez; Thomas K Waddell; Gary P Anderson; John A Hamilton; John W Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-25       Impact factor: 11.205

10.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Authors:  Eileen Goodwin; Morgan S A Gilman; Daniel Wrapp; Man Chen; Joan O Ngwuta; Syed M Moin; Patricia Bai; Arvind Sivasubramanian; Ruth I Connor; Peter F Wright; Barney S Graham; Jason S McLellan; Laura M Walker
Journal:  Immunity       Date:  2018-02-03       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.